CD9 and autoimmune thrombocytopenic purpura: We collected BM samples from additional five ITP patients and four healthy donors (Supplemental Table 1), and then tested the differentiation potential of CD9+Lin−CD34+CD45RA− HSPCs and CD9−Lin−CD34+ CD45RA− HSPCs sorted from every sample using liquid culture assays (Fig. 5c).